PMCB PharmaCyte Biotech Inc

PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (MyMD) a clinical stage biopharmaceutical...

PharmaCyte Biotech, Inc. (NASDAQ:PMCB Get Free Report)s stock price dropped 1.6% during mid-day trading on Tuesday . The stock traded as low as $2.34 and last traded at $2.44...

PharmaCyte Biotech, Inc. (NASDAQ:PMCB Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 26,500 shares, a...